Chronic low-grade inflammation often presents not as obvious swelling but as subtle, persistent symptoms. Issues like increased fatigue, difficulty concentrating, poor sleep, and skin problems can be driven by an under-the-radar inflammatory state that even doctors may miss.

The initial symptoms of Frontotemporal Dementia (FTD) are subtle and often mistaken for marital issues, hearing loss, or personality shifts. Unlike more obvious diseases, FTD “whispers, it doesn’t scream,” making it difficult for families to recognize the onset of a neurological condition versus a rough patch in their relationship.

The guest connects the public safety crisis of mass shootings to untreated brain injuries in military veterans. Citing that 31% of mass shooters are veterans, he argues the issue is a neurological condition (CTE) causing them to act erratically, not a moral or ideological failing. Treating brain inflammation could be a key preventative measure.

Doctors are often trained to interpret symptoms arising after stopping psychiatric medication as a relapse of the original condition. However, these are frequently withdrawal symptoms. This common misdiagnosis leads to a cycle of re-prescription and prevents proper discontinuation support.

Despite evidence of its effectiveness for conditions like CTE, hyperbaric oxygen therapy (HBOT) is not widely used due to its high cost and lack of insurance coverage. A full treatment course can exceed $12,000, making it inaccessible for most patients, including veterans and former athletes who need it most.

Frontotemporal Dementia (FTD) is tricky to diagnose because it primarily affects the frontal and temporal lobes, which control behavior and language, not memory. A person with FTD can easily pass standard cognitive tests designed for Alzheimer's, leading to dangerous misdiagnoses and delaying proper support.

Chronic issues like fatigue, moodiness, and brain fog are frequently dismissed as inevitable side effects of getting older. However, these are often direct symptoms of underlying environmental health problems, such as mold exposure or parasites, that can be addressed.

Hyperbaric oxygen therapy (HBOT) treats CTE by increasing atmospheric pressure, simulating being underwater. This allows blood to behave like a gas, enabling oxygen to bypass blockages and reduce inflammation in the brain. This same effect is achieved through deep-sea diving, which is used as a treatment in Europe.

A key challenge in treating CTE is that individuals with the condition, such as athletes and veterans, often lack self-awareness of their cognitive and behavioral changes. They can recognize symptoms in others but not themselves. This makes it essential for family and friends to identify out-of-character behavior and guide them toward help.